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During 2005–2006, nine measles virus (MV) genotypes 
were identiﬁ  ed throughout the World Health Organization 
European Region. All major epidemics were associated 
with genotypes D4, D6, and B3. Other genotypes (B2, D5, 
D8, D9, G2, and H1) were only found in limited numbers of 
cases after importation from other continents. The genetic 
diversity of endemic D6 strains was low; genotypes C2 and 
D7, circulating in Europe until recent years, were no longer 
identiﬁ   ed. The transmission chains of several indigenous 
MV strains may thus have been interrupted by enhanced 
vaccination. However, multiple importations from Africa and 
Asia and virus introduction into highly mobile and unvac-
cinated communities caused a massive spread of D4 and 
B3 strains throughout much of the region. Thus, despite the 
reduction of endemic MV circulation, importation of MV from 
other continents caused prolonged circulation and large out-
breaks after their introduction into unvaccinated and highly 
mobile communities.
T
he World Health Organization (WHO) has a goal of 
eliminating measles in the WHO European Region 
by 2010. The region extends from the Atlantic to the Pa-
ciﬁ  c, including all western and eastern European countries 
and the former Soviet Republics (online Appendix Table, 
available from www.cdc.gov/EID/content/14/1/107-appT.
htm). After the separation of Serbia and Montenegro in 
2006, the number of countries in the WHO European Re-
gion increased from 52 to 53. Within a well-performing 
case-based nationwide surveillance system, countries with 
a goal of elimination are expected to reach <1 conﬁ  rmed 
measles case per million population per year. To reach this 
goal countries are expected to achieve measles vaccination 
coverage of at least 95% with the ﬁ  rst dose and at least 80% 
with the second (1). From 1995 through 2005, the number 
of countries in the WHO European Region that reported 
>95% coverage with a ﬁ   rst dose of measles-containing 
vaccine increased from 18 (35.3%) of 51 to 31 (59.6%) of 
52. In 2005 and 2006, however, at least 40% and 55%, re-
spectively, of the member states had a measles incidence 
that was above the elimination threshold (online Appendix 
Table). A total of 36,426 and 55,578 measles cases, includ-
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ing 14 and 9 fatal cases, were reported in 2005 and 2006, 
respectively (online Appendix Table). Thus, measles con-
tinues to affect a large number of persons, despite enhanced 
vaccination strategies.
The pattern of measles virus (MV) genotypes, in com-
bination with epidemiologic investigation, contributes to 
understanding measles transmission and helps distinguish 
between continuous circulation and importation and lim-
ited transmission of the viruses in a certain region (2,3). 
Genotype C2 has been continuously detected in the Euro-
pean Region since the early 1970s and is therefore con-
sidered to be the indigenous genotype of Europe (4,5). D6 
viruses have been regularly reported from different coun-
tries of the European Region since the early 1990s (4–12), 
and genotype D6–associated outbreaks or sporadic cases 
on other continents were mostly due to MV importations 
from Europe (13–15) (Figure 1). These observations thus 
provide overwhelming evidence for the endemic circula-
tion of genotype D6 in Europe at least during the past 15 
years. Measles cases in the European Region associated 
with other genotypes were mostly due to virus importation 
from other continents 
Methods
Laboratory case conﬁ  rmation and MV genotyping have 
increased signiﬁ  cantly since the establishment of a global 
laboratory network for measles and rubella in 2000 (16). 
During 2005–2006, MV genotypes were identiﬁ  ed in 25 of 
the 53 member states of the WHO European Region (on-
line Appendix Table). Most epidemics and sustained trans-
missions were associated with genotypes D6, D4, and B3 
viruses (online Appendix Figure 1, available from www.
cdc.gov/EID/content/14/1/107-appG1.htm). All strains 
were genotyped by sequencing the 450 nt that code for 
the C-terminus of the MV N protein (hypervariable region 
[HVR]), as recommended by WHO (17). Sequencing was 
performed in different laboratories of the WHO laboratory 
network for measles and rubella.
Results
Genotype D6
During 2005–2006, genotype D6 viruses were re-
ported from 17 of the 53 countries in the WHO European 
Region. The overall diversity between these viruses was 
relatively low (Figure 2), with a maximum genetic distance 
of 7 nt (1.6%) in the HVR of the N gene. Two main vari-
ants, D6–2000 and D6–2005, differing by a single point 
mutation, accounted for most of genotype D6–associated 
cases and outbreaks.
The D6–2000 variant was predominant in the Russian 
Federation throughout 2005 and early 2006 (Figure 2) and 
was also detected in neighboring Kazakhstan (2006) and 
Uzbekistan (2006). Moreover, the D6–2000 strain caused 
outbreaks in Germany (March 2005–July 2005) (18) and 
Greece (September 2005–May 2006) (19) and was found 
in sporadic cases in Denmark (2005), Israel (2005, after 
importation from Georgia), and Switzerland (2006) (Fig-
ure 2). Because the same variant was reported throughout 
2000–2005 from different European countries (Figure 1), 
the cases in 2005 and 2006 were most probably due to en-
demic transmission of MV in the European Region.
The D6–2005 variant caused the large outbreak in the 
Ukraine, which had >45,000 cases reported between the last 
quarter of 2005 and October 2006 (20) and was ﬁ  rst identi-
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Figure  1. Phylogenetic tree showing representative genotype 
D6 strains identiﬁ   ed in Europe before 2005, strains exported 
from Europe to other continents (source of exportation is shown 
in brackets), and the D6 variants that were dominant in Europe 
during 2005 (D6–2000) and 2006 (D6–2005). The phylogenetic 
tree was calculated on the basis of the 450 nt that code for the 
C-terminus of the MV N protein, by using MEGA 3.1 software and 
the neighbor-joining method (500 bootstraps). Genetic distances 
are represented as numbers of nucleotide differences between 
strains. Measles virus strains were named according to World 
Health Organization nomenclature: MVi/City of isolation.Country/
epidemiologic week.year of isolation(/isolate number). Sequences 
obtained from RNA extracted from isolates (MVi) or clinical material 
(MVs) were distinguished. GenBank accession nos. are also shown 
for each strain.High Genetic Diversity of Measles Virus, European Region
ﬁ  ed during the last quarter of 2005 in the Russian Federa-
tion (MVs/Vladimir.RUS/40.05, Figure 2). The same virus 
was also found in Azerbaijan during the ﬁ  rst quarter of 
2006. Of the 32 viruses collected during the Ukraine out-
break, all but 6 were identical to the D6–2005 strain. The 
other 6 viruses correspond to 3 other variants that differ 
from the main variant by only single mutations.
Several other measles outbreaks and sporadic cases in 
2006 were epidemiologically linked to the Ukraine. Mul-
tiple importations of MV from the Ukraine caused different 
small outbreaks and sporadic cases in Belarus from January 
through September 2006 (21). Among the 47 Belarusian 
viruses that were sequenced, 37 were identical to the main 
variant from the Ukraine. The other 10 isolates differed 
by no more than a single nucleotide from D6 viruses from 
the Ukraine or the Russian Federation collected during the 
same period (Figure 2). In Russia in 2006, the main vari-
ant from the Ukraine had largely replaced the earlier D6 
strains. More than 94% of all genotype D6 strains (n = 88) 
obtained in the Russian Federation from the last quarter of 
2005 and all of 2006 were D6–2005 variants. Although the 
D6–2005 variant was ﬁ  rst reported from the Russian Fed-
eration, it may also have been imported from other coun-
tries that did not report MV genotypes despite signiﬁ  cant 
numbers of measles cases (online Appendix Table).
The D6–2005 virus was also retrieved from a small 
outbreak in Tallinn (Estonia) during March 2006; the in-
dex patient was infected in the Ukraine (MVs/Tallinn.
EST/12.06). Similarly, 2 persons infected with the same 
strain traveled from the Ukraine to Latvia and Bulgaria 
in April and July 2006, but the virus did not spread. In 
Spain, the same variant was also obtained from 2 sporad-
ic cases, (MVs/Madrid.SPA/18.06/1 and MVs/Valencia.
SPA/17.06), which were epidemiologically linked to the 
Ukraine, as well as from a small outbreak occurring in La 
Rioja (MVs/Logrono.SPA/02.06/1) from December 2005 
through January 2006 (22).
In Germany, the D6–2005 variant caused 2 sporadic cas-
es in Kiel and Stuttgart as well as a major outbreak in North 
Rhine Westphalia (MVs/Moenchengladbach.DEU/10.06 
(23,24) and a small outbreak in Berlin. Although the index 
cases of the 2 outbreaks were not found, sequence identity 
with the main Ukrainian variant suggests that they were di-
rectly or indirectly linked to the outbreak in the Ukraine. In 
the United Kingdom (UK, March–July 2006) another out-
break associated with D6–2005 (MVs/Redhill.GBR/10.06) 
was epidemiologically linked to Italy, although genotype D6 
had not been directly detected in this country.
In addition to the main genotype D6 variants, D6–
2000 and D6–2005, somewhat different viruses were found 
in Greece, Germany, Spain, and Luxembourg. Besides the 
D6–2000 virus, a second genotype D6 variant (MVs/At-
tica.GRC/09/06/2), with a 2-nt difference, was identiﬁ  ed in 
Athens during February 2006. The same virus was also ob-
tained from a sporadic case in Munich (Germany) 10 weeks 
later and caused an outbreak in the Canary Islands (Spain) 
after importation from Germany (Figure 2). Another geno-
type D6 virus identiﬁ  ed in a sporadic case from Luxem-
bourg in April 2006 showed a 4-nt difference from the most 
closely related D6 strain. In absence of an epidemiologic 
link, the origin of these viruses could not be determined.
Genotype D4
In contrast to the relative genetic homogeneity of D6 
viruses, at least 4 distinct genetic groups of genotype D4 
were identiﬁ  ed in Europe during 2005–2006 (Figure 3). 
The maximum genetic distance was 24 nt (5.3%), and the 
minimum distance between 2 groups was 11 nt (2.4%).
Group 1
A large outbreak in Romania, which included >8,000 
cases and lasted from December 2004 until early 2007, 
started among unvaccinated members of the Roma and 
Sinti communities before spreading to the general popu-
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Figure 2. Two main variants, D6–2000 and D6–2005, of D6 identiﬁ  ed 
in Europe during 2005–2006. Tree calculation and measles virus 
nomenclature are as delineated in Figure 1.RESEARCH
lation. Viruses differing by <2 nt were identiﬁ  ed during 
different phases of this outbreak (Figure 3). All group 1 
viruses identiﬁ  ed in other countries differed from the most 
closely related Romanian virus by a maximum of 2 nt. Vi-
ruses identical to MVs/Bucharest.ROM/48.04/2 were re-
ported from an outbreak of >220 cases in Germany (Hesse, 
January–April 2005; MVs/Frankfurt.DEU/03.05), which 
was epidemiologically linked to Romania (18), and from 
small outbreaks in Berlin (Germany), Guimares (Portu-
gal), and an isolated case in Aarau (Switzerland) during 
2005 (Figure 3). The MVs/Bucharest.ROM/47.05 variant 
was found in 2 different small outbreaks in Spain during 
weeks 7 and 22 of 2006 (MVs/Barcelona.SPA/07.06/2 and 
MVs/Valencia.SPA/22.06/2), the ﬁ  rst case of which could 
be directly epidemiologically linked to Romania. The same 
variant was also found in Roma populations in Serbia as 
well as in Bosnia and Herzegovina during the ﬁ  rst quar-
ter of 2007. Another small outbreak in Cataluña (Spain) 
was also caused by a virus imported from Romania (MVs/
Tarragona.SPA/27.05/1), with a single mutation compared 
with MVs/Bucharest.ROM/48.04/2. Finally, the virus that 
caused an outbreak of >200 cases in Barcelona (MVs/Bar-
celona.SPA/41.06/1; August 2006–February 2007) (25) 
was imported from Italy and had differed by 1 nt from those 
from an epidemic in the region of Lazio (Italy, June–No-
vember 2006), which were also taken by Roma populations 
to Sardinia in August 2006. A closely related genotype D4 
variant, identical to MVs/Bucharest.ROM/04.06/6, caused 
a small outbreak during the same period in South Tyrol 
(Italy, Figure 3) (26).
The source of the Romanian viruses could not be iden-
tiﬁ  ed. However, the homogeneity of D4 viruses identiﬁ  ed 
during the Romanian outbreak, as well as the large number 
of measles-susceptible persons, suggests that the virus has 
spread within the country only after importation from an-
other country.
Group 2
MV variants of a second group were found in the UK 
and Spain (Figure 3). MVs/Madrid.SPA/50.05 had been 
imported from the UK into Spain but had 1 point mutation 
compared with MVs/London.GBR/37.05. These viruses 
had 1 or 2 mutations compared with D4 viruses detected 
earlier in Kenya (2002) and Ethiopia (2003), which sug-
gests an East African origin. The putative epidemiologic 
link to Somalia for MVs/London.GBR/37.05 also supports 
this hypothesis.
Group 3
Group 3 includes mainly viruses identiﬁ  ed in different 
outbreaks and sporadic cases in the UK throughout 2005–
2006, as well as in Greece, Albania, and Denmark (Figure 
3). Although the source could not be identiﬁ  ed for all group 
3 viruses, the overall genetic diversity in this group (7 nt, 
1.6%) suggests multiple origins. Conﬁ  rmed epidemiologic 
links to Pakistan for MVs/London.GBR/7.06/3, MVs/Bir-
mingham.GBR/18.06/2, MVs/Manchester.GBR/01.06, and 
the Danish strains suggest that most of them were imported 
from Central Asia, where genotype D4 is still endemic (27). 
The genotype D4 virus, which caused a small outbreak in 
Albania during June 2006, was imported from Greece by 
Roma populations.
Group 4
In Germany and Denmark (February and April 2006), 
closely related viruses of this group were found in different 
outbreaks and sporadic cases, which could not be epide-
miologically linked to each other (Figure 3). The Danish 
virus (MVs/Odense.DEN/24.06) was imported from Leba-
non, which is perhaps consistent with the isolation of simi-
lar D4 strains in Israel 2004 (1-nt difference). Conversely, 
closely related strains (with a 1- to 2-nt difference) were 
also seen in Ethiopia (2003) and the Sudan (2004), which 
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Figure 3. Four different genetic groups of genotype D4 identiﬁ  ed 
in Europe during 2005–2006 and their closest relatives (in italics) 
identiﬁ  ed on other continents. Tree calculation and measles virus 
nomenclature are as delineated in Figure 1.High Genetic Diversity of Measles Virus, European Region
suggests that the corresponding strains from Germany may 
also have been imported from East Africa. Another D4 
variant of group 4 caused an outbreak in Tuscany (Italy, 
January–May 2006; MVs/Grosseto.ITA/38.06) after im-
portation from India (26). This virus differed by only 3 nt 
from the D4 strains obtained from an outbreak in Poland 
that occurred from January through May 2006.
Genotype B3
During 2005–2006, B3 strains were reported from 8 
European countries, in association with outbreaks of vari-
ous sizes. The maximum genetic distance between the cor-
responding viruses was 13 nt (2.9%) (Figure 4).
A sporadic case in the Netherlands (MVs/Gouda.
NET/47.05) resulted from contact with a measles patient 
from Kenya at the airport in Newark, New Jersey, USA (28). 
The same virus was identiﬁ  ed during an outbreak in Germa-
ny (January–April 2006) and the UK (June 2006) (Figure 4). 
Although it was not clear whether these outbreaks were due 
to independent importations from Africa or to MV transmis-
sion within Europe, the very high genetic diversity of MV in 
Africa would suggest the latter. Three other B3 variants were 
identiﬁ  ed in the UK during May/June 2005 and May 2006. 
Although the sources are unknown, their genetic distance of 
3–6 nt suggests independent importations from sub-Saharan 
Africa. The most closely related virus from sub-Saharan Af-
rica (MVs/Ibadan.NGA/05.04) was identical to MVs/Lon-
don.GBR/19.05, which was the cause of a major outbreak in 
the UK. On the other hand, 2 B3 viruses with a single muta-
tion in comparison with MVs/London.GBR/19.05 from the 
UK caused 2 independent outbreaks in Spain (Madrid and 
Las Palmas, 2006).
Another B3 variant was detected in Denmark, Sweden, 
and Spain in 2006 (Figure 4). The corresponding measles 
cases in Denmark and Sweden were most probably epide-
miologically linked (29), but the source of importation into 
Europe could not be identiﬁ  ed. The closest non-European 
virus (MVs/Ibadan.NGA/01.04), which differed by 1 nt, 
was from Nigeria (2004). 
Identical B3 strains were identiﬁ  ed during the last quar-
ter of 2006 in Albania and Italy (MVs/Roma.ITA/43.06/2 
and MVi/Shkodra.ALB/44.06). Two considerably different 
B3 strains were found within a period of 3 weeks in Caen, 
France, in 2005. The latter clustered with viruses from ei-
ther Cameroon and Equatorial Guinea or Democratic Re-
public of the Congo, respectively, indicating that they re-
sulted from 2 independent introductions (Figure 4). Finally, 
another B3 variant was obtained from a sporadic case in 
Switzerland in 2006.
Other Genotypes
In addition to D6, D4, and B3, some other genotypes 
(B2, D5, D8, D9, G3, H1) were found in Europe during 
2005–2006 (online Appendix Figure 2, available from www.
cdc.gov/EID/content/14/1/107-appG2.htm). Most of them 
were associated with sporadic cases or small outbreaks af-
ter importation of MV from other continents. The corre-
sponding strains and conﬁ  rmed sources of importation are 
shown in online Appendix Figure 2.
Discussion
All 53 member states of the WHO European Region 
except 1 have implemented a routine vaccination program 
against measles, resulting in an overall regional coverage 
of 94% for the ﬁ  rst dose of measles-containing vaccine. In 
2006, 45% of the member states had reached an incidence 
of <1/1,000,000 population (online Appendix Table), the 
threshold to declare measles elimination. To achieve re-
gional elimination of measles by 2010, enhanced vaccina-
tion strategies are required, especially in countries with a 
persistently high measles incidence.
Molecular epidemiology, an essential component of 
measles surveillance, helps to distinguish between endemic 
transmission and importation of the virus. It enables iden-
tiﬁ  cation of regions with continued MV circulation, which 
reﬂ  ect suboptimal herd immunity. During 2005–2006, 9 of 
the 17 active MV genotypes (27) were found in the WHO 
European Region. The major epidemics were caused by 
different variants of genotypes D4, D6, and B3. The largest 
outbreaks occurred in the Ukraine (genotype D6, >45,000 
as of June 2007), Romania (D4, >8,000 cases as of June 
2007), Germany (North Rhine Westphalia, D6, ≈1,700 
cases), and the Russian Federation (D6, >1,100 cases). Ep-
idemics involving 100–500 cases were reported from the 
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Figure 4. Genotype B3 variants identiﬁ  ed in Europe during 2005–
2006 and some closely related strains identiﬁ  ed on other continents 
(in italics). Tree calculation and measles virus nomenclature are as 
delineated in Figure 1.RESEARCH
UK (B3, originated in a traveler community), Spain (B3, 
D4), Germany (D4, D6, B3), Italy (D4), Belarus (D6), and 
Greece (D6, D4). Smaller epidemics and sporadic cases 
were caused by either the above-mentioned genotypes or 
others (B2, D5, D8, D9, H1, G3).
Since the early 1990s, genotype D6 has been continu-
ously detected in Europe (4–12). During 2005–2006, D6 
strains were reported from 17 European countries and were 
mostly related to the large outbreak in the Ukraine (online 
Appendix Table). The overall genetic diversity of the re-
cent D6 strains was, however, much lower than that found 
during the 1990s and early 2000s, and recent D6 strains 
were most similar to those found during 2000–2004 mainly 
in the Russian Federation and Turkey (Figure 1). The low 
genetic diversity of D6 strains suggests that enhanced vac-
cination has largely reduced the cocirculation of highly di-
verse D6 variants in Europe. Moreover, genotypes C2 and 
D7, which were frequently identiﬁ  ed in Europe until 2004 
(4–8,10–12), were no longer found during the past 2 years, 
despite greatly improved virologic surveillance. Genotype 
C2 had been continuously identiﬁ  ed in the European Re-
gion since the early 1970s, and genotype D7 had partially 
replaced genotypes C2 and D6 in Germany during 2000–
2004 (6). Thus, the transmission of several indigenous MV 
strains from Europe has probably been interrupted by en-
hanced control programs.
In contrast, the prevalence of imported genotype D4 
and B3 strains considerably increased during 2005–2006. 
Genotype D4 strains have a vast geographic distribution, 
and measles outbreaks associated with this genotype have 
been reported from all continents (5). D4 viruses are still 
endemic on the Indian subcontinent as well as in East and 
South Africa (5,27). Although some outbreaks and sporadic 
cases associated with genotype D4 had been reported from 
Europe, the corresponding viruses were mostly imported 
from other continents and differed considerably from the 
more recent strains (6,11,30). In 2005–2006, genotype D4 
was found in 16 of the 27 countries in which MV has been 
genotyped; most of the corresponding viruses were related 
to the outbreak in Romania. Roma and Sinti, communities 
which had mostly low vaccination levels, were involved 
in the transmission of the Romanian D4 viruses to at least 
10 other countries in Europe. The remaining genotype 
D4–associated cases from Europe (2005–2006) were often 
epidemiologically linked to the Indian Subcontinent, East 
Africa, and the Middle East. The high genetic diversity of 
the corresponding MV variants is characteristic of multiple 
importation events. The increased frequency of genotype 
D4 detection during recent years can be explained by the 
interruption of transmission of most of the indigenous 
strains, as well the introduction of genotype D4 strains into 
highly mobile and hard-to-reach populations with low vac-
cination levels.
Genotype B3 is the endemic genotype in sub-Saharan 
Africa; a large diversity of genotype B3 viruses continues 
to circulate in many countries of West and Central Africa 
(31–37). Before 2005, genotype B3 viruses had only been 
reported sporadically from Europe (6,11). The genetic 
diversity of the multiple B3 variants detected in Europe 
during 2005–2006 suggests that each one was directly or 
indirectly imported from sub-Saharan Africa. All of them 
belonged to subgroup B3.1 of genotype B3, a ﬁ  nding that 
suggests a high prevalence of B3.1 strains in Africa during 
2005–2006.
Several other imported genotypes (B2, D5, D8, D9, 
G2, and H1), which usually do not occur in Europe, were 
also sporadically detected during 2005–2006. Sequence 
analysis conﬁ  rmed or identiﬁ  ed suspected sources of im-
portation for most of these.
While some countries reported outbreaks caused by a 
single strain, other countries experienced epidemics that 
were caused by multiple importations of unrelated strains. 
As an example, the isolation of different genetic variants 
(D4, B3, D6–2000, D6–2005) from the 4 major epidem-
ics in Germany (2005–2006) shows that these cases were 
not epidemiologically linked. The identiﬁ  cation of multiple 
genotypes in Spain, Switzerland, and the UK also dem-
onstrates multiple origins of the different outbreaks and 
sporadic cases. Cocirculation of different genotypes dur-
ing what seemed to be 1 outbreak has been identiﬁ  ed in 
Greece, Italy, and Germany. In Italy (Lazio region, 2006) 
and Greece (2006), viruses obtained toward the end of an 
epidemic (genotype B3 and D4) belonged to genotypes dif-
ferent from those found in the early phase (D4 and D6). 
In Germany very different variants of genotype D4 were 
found in distinct parts of the country simultaneous with the 
epidemic in North Rhine Westphalia. In Denmark (2006), 
the detection of genotypes B3 and D5 and 2 D4 variants 
occurred in close geographic and temporal proximity (38). 
The identiﬁ  cation of genotype D4 in Poland did not cor-
roborate the putative epidemiologic link between the out-
breaks in Poland and the Ukraine (genotype D6) (39). The 
presence of both genotypes D4 and D6 in Poland can, how-
ever, not be excluded because no viruses were character-
ized from the early phase of what seemed to be 1 epidemic. 
The corresponding examples from Germany, Italy, Greece, 
Denmark, and Poland thus highlight the importance of MV 
genotyping during different phases of a presumably single 
protracted outbreak. On the other hand, MV genotyping 
alone may not always be sufﬁ  cient to distinguish linked 
and unlinked outbreaks caused by multiple importations. 
Epidemiologic investigations in Belarus showed multiple 
importations from the Ukraine that caused different, unre-
lated outbreaks and sporadic cases in which highly similar 
or identical D6 variants were found.
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Conclusion
In conclusion, the absence of previously circulating 
genotypes (C2 and D7) and the low genetic diversity of D6 
strains during 2005–2006 suggest an interruption of several 
MV transmission chains in the WHO European Region at-
tributable to enhanced vaccination. However, the virus con-
tinues to be imported from other continents where measles 
remains highly endemic. Moreover, prolonged circulation 
and spread of imported strains, mostly after introduction 
into unvaccinated and highly mobile communities, contin-
ue to cause a high incidence of measles disease in Europe. 
Some countries did not report measles genotypes despite 
large numbers of cases (online Appendix Table). As a con-
sequence, to achieve measles elimination by 2010, measles 
surveillance and control need to be further optimized, and 
speciﬁ  c emphasis must be given to the vaccination of hard-
to-reach populations. 
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